Perinatal TCDD exposure and the adult onset of autoimmune disease

References

• Antignac, J. P., Marchand, P., Gade, C., Matayron, G., el Qannari, M., Le Bizec, B. and Andre, F. 2006. Studying variations in the PCDD/PCDF profile across various food products using multivariate statistical analysis. Anal. Bioanal. Chem. 384:271–279.
   PubMed Web of Science ®Google Scholar
• Baccarelli, A., Mocarelli, P., D. G., Patterson, Jr., Bonzini, M., Pesatori, A. C., Caporaso, N. and Landi, M. T. 2002. Immunologic effects of dioxin: New results from Seveso and comparison with other studies. Environ. Health Perspect. 110:1169–1173.
   PubMed Web of Science ®Google Scholar
• Baron, F., Gothot, A., Salmon, J.P., Hermanne, J. P., Pierard, G. E., Fillet, G. and Beguin, Y. 2000. Clinical course and predictive factors for cyclosporine-induced autologous graft-versus-host disease after autologous hematopoietic stem cell transplantation. Br. J. Haematol. 111:745–753.
   PubMed Web of Science ®Google Scholar
• Besteman, E. G., Zimmerman, K. L. and Holladay, S. D. 2005. Tetrachlorodibenzo-p-dioxin (TCDD) inhibits differentiation and increases apoptotic cell death of precursor T-cells in fetal mouse thymus. J. Immunotoxicol. 2:107–114.
   PubMedGoogle Scholar
• Blaylock, B. L., Ahmed, S. A. and Holladay, S. D. 2005. Prenatal immunotoxicant exposure and autoimmune disease. In: Developmental Immunotoxicology, (S. D., Holladay, Ed.), Boca Raton, FL: CRC Press, pp. 215–228.
   Google Scholar
• Blaylock, B. L., Holladay, S. D., Comment, C. E., Heindel, J. J. and Luster, M. I. 1992. Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol. Appl. Pharmacol. 112:207–213.
   PubMed Web of Science ®Google Scholar
• Boverhoff, D. R., Tam, E., Harney, A. S., Crawford, R. B., Kaminski, N. E. and Zacharewski, R. 2004. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B-cells. Mol. Pharmacol. 66:1662–1670.
   PubMed Web of Science ®Google Scholar
• Camacho, I. A., Nagarkatti, M. and Nagarkatti, P. S. 2004. Evidence for induction of apoptosis in T-cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 78:96–106.
   PubMed Web of Science ®Google Scholar
• Cariappa, A., Tang, M., Parng, C., Nebelitskiy, E., Carroll, M., Georgopoulos, K. and Pillai, S. 2001. The follicular versus marginal zone B-lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603–615.
   PubMed Web of Science ®Google Scholar
• Collins, J. J., Acquavella, J. F. and Friedlander, B. R. 1992. Reconciling old and new findings in dioxin. Epidemiology 3:65–69.
   PubMed Web of Science ®Google Scholar
• DeWaal, E. J., Schuurman, H. J., Loeber, J. G., Van Loveren, H. and Vos, J. G. 1992. Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): An (immuno)histological study. Toxicol. Appl. Pharmacol. 115:80–88.
   PubMed Web of Science ®Google Scholar
• Dong, L., Ma, Q. and Whitlock, J. P. 1997. Down-regulation of major histocompatibility complex Q1b gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 272:29614–29619.
   PubMed Web of Science ®Google Scholar
• Esser, C., Steinwachs, S., Herder, C., Majora, M. and Lai, Z. 2005. Effects of a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin given at post-puberty, in senescent mice. Toxicol. Lett. 157:89–98.
   PubMed Web of Science ®Google Scholar
• Fingerhut, M.A., Steenland, K., Sweeney, M. H., Halperin, W. E., Piacitelli, L. A. and Marlow, D. A. 1992. Old and new reflections on dioxin. Epidemiology 3:66–72.
   Web of Science ®Google Scholar
• Fujimoto, M. and Sato, S. 2007. B-Cell signaling and autoimmune diseases: CD19/CD22 loop as a B-cell signaling device to regulate the balance of autoimmunity. J. Dematol. Sci. 46:1–9.
   PubMed Web of Science ®Google Scholar
• Gehrs, B. C. and Smialowicz, R. J. 1999. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 134:79–88.
   PubMed Web of Science ®Google Scholar
• Gehrs, B. C. and Smialowicz, R. J. 1997. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: I. Effects on the fetus and the neonate. Toxicology 122:219–228.
   PubMed Web of Science ®Google Scholar
• Gehrs, B. C., Riddle, M. M., Williams, W. C. and Smialowicz, R. J. 1997. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: II. Effects on the pup and the adult. Toxicology 122:229–240.
   PubMed Web of Science ®Google Scholar
• Hanawa, H., Tsuchida, M., Matsumoto, Y., Watanabe, H., Abo, T., Sekikawa, H., Kodama, M., Zhang, S., Izumi, T. and Shibata, A. 1993. Characterization of T-cells infiltrating the heart in rats with experimental autoimmune myocarditis. Their similarity to extrathymic T-cells in mice and the site of proliferation. J. Immunol. 150:5682–5695.
   PubMed Web of Science ®Google Scholar
• Hess, A. D., Fischer, A. C. and Beschorner, W. E. 1990. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets. J. Immunol. 145:526–533.
   PubMed Web of Science ®Google Scholar
• Holladay, S. D. 1999. Prenatal immunotoxicant exposure: Increased risk of postnatal autoimmune disease? Environ. Health Perspect. 107:687–691.
   PubMed Web of Science ®Google Scholar
• Holladay, S. D. and Luster, M. I. 1996. Alterations in fetal thymic and liver hematopoietic cells as an indicator of exposure to developmental immunotoxicants. Environ. Health Perspect. 104:809–813.
   PubMed Web of Science ®Google Scholar
• Holladay, S. D., Lindstrom, P., Blaylock, B. L., Comment, C. E., Germolec, D. R., Heindel, J. J. and Luster, M. I. 1991. Perinatal thymocyte antigen expression and postnatal immune development altered by exposure to tetrachlorodibenzo-p-dioxin (TCDD). Teratology 44:385–393.
   PubMedGoogle Scholar
• Holladay, S.D. and Smialowicz, R.J. 2000. Development of the immune system: Differential effects depending on time of exposure. Environ. Health Perspect 108:463–473.
   PubMed Web of Science ®Google Scholar
• Holsapple, M. P., Snyder, N. K., Wood, S. C. and Morris, D. L. 1991. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 69:219–255.
   PubMed Web of Science ®Google Scholar
• Kakkanaiah, V. N., Pyle, R. H., Nagarkatti, M. and Nagarkatti, P. S. 1990. Evidence for major alterations in the thymocyte subpopulations in murine models of autoimmune diseases. J. Autoimmunity 3:27–28.
   PubMed Web of Science ®Google Scholar
• Kamath, A. B., Xu, H., Nagarkatti, P. S. and Nagarkatti, M. 1997. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Appl. Pharmacol. 142:367–377.
   PubMed Web of Science ®Google Scholar
• Knutson, J. C. and Poland, A. 1982. Response of murine epidermis to 2,3,7,8-tetrachlorodibenzon-p-dioxin: Interaction of the ah and hr loci. Cell 30:225–234.
   PubMed Web of Science ®Google Scholar
• Kosugi, A., Zuniga-Pflunker, J. C., Sharrow, S. O., Kruisbeek, A. M. and Shearer, G. M. 1989. Effect of cyclosporin A on lymphopoiesis. II. Developmental effects on immature thymocytes in fetal thymus organ culture treated with cyclosporin A. J. Immunol. 143:3134–3140.
   PubMed Web of Science ®Google Scholar
• Kruisbeek, A. M., Bridges, S., Carmen, J., Longo, D. L. and Mond, J. J. 1985. In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the Class I, Class II, and Mls-reactive proliferating T-cell subset. J. Immunol. 134:3597–3604.
   PubMed Web of Science ®Google Scholar
• Martin, F. and Chan, A. C. 2006. B-Cell immunobiology in disease: Evolving concepts from the clinic. Annu. Rev. Immunol. 24:467–496.
   PubMed Web of Science ®Google Scholar
• Mustafa, A., Holladay, S. D., Goff, M., Witonsky, S., Kerr, R., Reilly, C., Sponenberg, P. and R. M., Gogal, Jr. An enhanced postnatal autoimmune profile in 24-week-old C57BL/6 mice developmentally-exposed to TCDD. Toxicol. Appl. Pharmacol. (In press).
   Web of Science ®Google Scholar
• Neubert, R., Jacob-Muller, U., Stahlmann, R., Helgo, H. and Neubert, D. Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulation of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD). Arch. Toxicol. 64:345–359.
   PubMed Web of Science ®Google Scholar
• Okuyama, R., Abo, T., Seki, S., Ohteki, T., Sugiura, K., Kusumi, A. and Kumagai, K. 1992. Estrogen administration activates extrathymic T-cell differentiation in the liver. J. Exp. Med. 175:661–669.
   PubMed Web of Science ®Google Scholar
• Reicke, K., Schmidt, A. and Stahlmann, R. 2003. Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro. Arch. Toxicol. 77:358–364.
   PubMed Web of Science ®Google Scholar
• Rijhsinghani, A. G., Thompson, K., Bhatia, S. K. and Waldschmidt, T. J. 1996. Estrogen blocks early T-cell development in the thymus. Am. J. Reprod. Immunol. 36:269–277.
   PubMed Web of Science ®Google Scholar
• Roberts, L. 1991. EPA moves to reassess the risk of dioxin. Science 252:911.
   PubMed Web of Science ®Google Scholar
• Rocha, B., Bassalli, P. and Guy-Grand, D. 1992. The extrathymic T-cell development pathway. Immunol. Today 13:449–454.
   PubMedGoogle Scholar
• Rozman, K. 1989. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p- dioxin. Implications for human safety assessment. Derm. Beruf. Umwelt. 37:81–92.
   PubMedGoogle Scholar
• Silverstone, A. E., D. E., Frazier, Jr., Gasiewicz, T. A. 1994. Alternate immune system targets for TCDD: Lymphocyte stem cells and extrathymic T-cell development. Exp. Clin. Immunogenet. 11:94–101.
   PubMedGoogle Scholar
• Silverstone, A. E., Gavalchin, J. and Gasiewicz, T. A. 1998a. TCDD, DES, and estradiol potentiate a lupus-like autoimmune nephritis in NZB × SWR (SNF1) mice. Toxicologist 42:403.
   Google Scholar
• Silverstone, A. E., Gavalchin, J., Silvin, C. A., Staples, J. E., Ames, I. H. and Shanley, P. 1998b. Effects of 2,3,7,8-tetrachlorodibenzo-p- dioxin on a murine model of a lupus-like nephritis. Chemosphere 18:11–23.
   Google Scholar
• Sweeney, M. H. and Mocarelli, P. 2000. Human health effects after exposure to 2,3,7,8-TCDD. Food Add. Contam. 17:303–316.
   PubMed Web of Science ®Google Scholar
• Takahama, Y. 2006. Journey through the thymus: Stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6:127–135.
   PubMed Web of Science ®Google Scholar
• Weber, H. and Birnbaum, L. S. 1985. Dosing with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and with 2,3,7,8-tetrachlorodibenzo-p-furan (TCDF) in pregnant C57Bl/6N mice: Distribution and excretion. Arch. Toxicol. 57:159–162.
   PubMed Web of Science ®Google Scholar
• Weisglas-Kuperus, N. T., Sas, C. J., Koopman-Esserboom, C., Van Der Zwan, C. W., De Ridder, M. A., Beishuizen, A., Hooijkaas, H. and Sauer, P. J. 1995. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatr. Res. 38:404–410.
   PubMed Web of Science ®Google Scholar
• Zoller, A. L. and Kersh, G. J. 2006. Estrogen induces thymic atrophy by eliminating early thymic progenitors and inhibiting proliferation of β-selected thymocytes. J. Immunol. 176:7371–7378.
   PubMed Web of Science ®Google Scholar